🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Early Bird Registration Now Available! Join us in October 27- 29, 2023 in La Quinta, CA! cme.cityofhope.org/content/2023-m…

Join us for this important discussion on decision making and how to best make treatment decisions with our patients with #HCC

Amazing work lead by Dr. Marwan G. Fakih and team. Great for CRC patients moving forward. City of Hope City of Hope Department of Medical Oncology

Look forward to this upcoming exciting #SITC program to discuss the next generation of immunotherapy in GI cancers. Come join us. City of Hope City of Hope Department of Medical Oncology Jun Gong Mark Yarchoan Arsen Osipov, MD

Honored to lead the GI cohorts from COSMIC-021. Lack of activity in gastric/GE junction tumor. Signal in #HCC that led to COSMIC312. More work needed Sumanta K. Pal, MD, FASCO City of Hope Department of Medical Oncology City of Hope Cabozantinib plus atezolizumab in previously untreated advanced hepato... sciencedirect.com/science/articl…

Looking forward to a great discussion with Jun Gong on all the exciting data from ASCO #GI24

As #GI24 kicks off this weekend, mark your calendars for an exciting recap of the conference with hosts Jun Gong Daneng Li on Thursday 1/25 at 5:30 pm ET! #gicsm | ASCO Cedars-Sinai City of Hope

Happening tonight, Jun Gong and Daneng Li with co-host a Twitter Spaces focused on the most important data from #GI24, don't miss it! Cedars-Sinai City of Hope

Written by Dr. Vicky Forster. Featuring research by Drs Riccardo Lencioni from Università di Pisa, Kuang Ming from Sun Yat-sen University, Daneng Li from @CityofHope, and Jia-Yi Wu from Fujian Provincial Hospital.

Jun Gong, MD, and Daneng Li, MD, spoke about trials they feel can impact the gastrointestinal space during a CancerNetwork® X Space. #gicsm #GI24 | ASCO Jun Gong Daneng Li Cedars-Sinai City of Hope cancernetwork.com/view/expert-pe…

Ipi/Nivo meets OS endpoint for 1st line #HCC. Will be interesting to see the data given mix of Len or Sor comparator arm. Good news for pts that prior AA in the second line setting will likely be kept. news.bms.com/news/corporate…

Happy to share ongoing phase I dose escalation data for CF33-hNIS AACR #AACR24. Excellent safety and encouraging early efficacy even seen at low dose levels in refractory tumor types such as #cholangiocarcinoma #bileductcancer City of Hope Imugene | Cancer Immunotherapies City of Hope Department of Medical Oncology City of Hope Surgery

Patient preferences should be considered when making shared decisions about cancer therapy. In this analysis, City of Hope researchers explore outcome prioritization among older adults with cancer. #OpenAccess link: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… Enrique Soto OncoAlert

Happy to have this study published with Enrique Soto. Patient preferences matter among older adults with cancer receiving treatment. Hope we are continuing to make Arti proud. ACS Journal Cancer City of Hope City of Hope Department of Medical Oncology William Dale, MD, PhD, FASCO Vani Katheria canlan sun Mina S. Sedrak #gerionc

Out now, the Methods Full article: IMbrave152/SKYSCRAPER-14: a Phase III study of atezolizumab, bevacizumab and tiragolumab in advanced hepatocellular carcinoma tandfonline.com/doi/full/10.10…. 1st global study with Atezo/bev as comparator. Hopeful for #HCC pts. City of Hope City of Hope Department of Medical Oncology

📢Please join this week's educational webinar: "Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) for Cholangiocarcinoma Patients with Peritoneal Metastases" with Dr. Daneng Li and Dr. Mustafa Raoof from City of Hope in Duarte, CA. ⬆️Up to 20% of biliary tract cancer

Looks like an amazing presentation Lisa Yen @LACNETS Congrats. Honored to be part of the journey with you and your team.

The November issue of ONCOLOGY features a wide range of articles from those focused on survivorship, multiple myeloma and pleural effusion, and gender equity. Read the full issue here: cancernetwork.com/journals/oncol… Julie Vose John P Diaz MD Tom Martin Amy Comander MD, DipABLM Daneng Li

Thanks Po Hien Ear, PhD. It has been amazing Co-chairing this years symposium with you. Honored to moderate this great session City of Hope City of Hope Department of Medical Oncology #NANETS24

Honored to moderate this amazing session with wonderful colleagues Lisa Yen @drjasonstarr Alexandra Gangi, MD and Sandy B from Penn. NANETS @LACNETS #NANETS24